Last reviewed · How we verify
NCT02901509: QoLCHIK
Epidémie de Chikungunya à l'île de La Réunion : Effet à Dix Ans de l'Infection Sur la qualité de Vie Dans la Cohorte TELECHIK
trial in Chikungunya Fever in 386 participants. Completed in 31 May 2018.
31 May 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Réunion |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 386 |
| Start date | 1 June 2016 |
| Primary completion | 31 May 2018 |
| Estimated completion | 31 May 2018 |
| Sites | 1 location across France |
Conditions studied
- Chikungunya Fever — all drugs for Chikungunya Fever →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Centre Hospitalier Universitaire de la Réunion
Who can join
Adults 18 to 85, any sex, with Chikungunya Fever or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Mean score SF-36 health survey
Time frame: 1 year
Sponsor's own description
QoLCHIK study aims at evaluating impact of chikungunya infection on the quality of life of infected people during the 2005-2006 outbreak in Reunion Island and followed in the TELECHIK cohort by comparing scores of SF-36 health survey.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02901509
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chikungunya Fever
Currently open trials in the same condition.
- NCT07120724 — Real-World Study on Chinese Medicine for Treating Chikungunya Fever · recruiting
Other Centre Hospitalier Universitaire de la Réunion trials
Trials by the same sponsor.
- NCT06697262 — Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia · NA · not yet recruiting
- NCT07444515 — Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients. · NA · not yet recruiting
- NCT07190560 — Against Chikungunya Virus and Neonatal Infection · NA · not yet recruiting
- NCT07365670 — Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Int · NA · not yet recruiting
- NCT06485310 — Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary M · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02901509 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion
- Last refreshed: 4 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02901509.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing